Page 10 - Nasdaq Dcph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities researchers at Jefferies Financial Group lifted their Q2 2022 earnings estimates for Deciphera Pharmaceuticals in a research report issued on Wednesday, May 4th. Jefferies Financial Group analyst E. Yang now expects that the company will post earnings of ($0.70) per share for the quarter, up from […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Investment analysts at SVB Leerink increased their Q2 2022 earnings per share estimates for Deciphera Pharmaceuticals in a report issued on Wednesday, May 4th. SVB Leerink analyst A. Berens now forecasts that the company will earn ($0.55) per share for the quarter, up from their previous estimate […]

Equities analysts expect Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) to report earnings of ($0.84) per share for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Deciphera Pharmaceuticals’ earnings. The lowest EPS estimate is ($1.11) and the highest is ($0.61). Deciphera Pharmaceuticals posted earnings per share of ($1.06) during […]

Brokerages predict that Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) will announce sales of $26.82 million for the current quarter, Zacks reports. Seven analysts have provided estimates for Deciphera Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $22.80 million and the highest estimate coming in at $30.00 million. Deciphera Pharmaceuticals reported sales of […]